CLX vs GERN · P/E 15, rev $7.10B vs rev $109.3M
The Clorox Company (CLX) versus Geron Corporation (GERN) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Geron Corporation (GERN) is a biotechnology company listed on US.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. GERN currently screens at market cap $878.9M.
Not investment advice. Open the CLX and GERN stock pages for the full models.
Not investment advice.